NCT05474196

Brief Summary

Intubated patients with the acute respiratory distress syndrome (ARDS) are usually treated with protective ventilation limiting plateau pressure below 30 centimeter of water (cmH2O) and, if possible, a driving pressure under 15 cmH2O. However, these airway pressures might not reflect the actual pressure applied to the lung. Transpulmonary pressure is the difference between airway pressure and pleural pressure, the latter is estimated by the esophageal pressure, and so it better reflects the ventilatory induced lung injury (VILI). One of the consequences of the VILI is a increase of pulmonary edema and it could be estimated by the extravascular lung water, obtained by trans-pulmonary thermodilution. So it could exist a link between the driving trans-pulmonary pressure and the extravascular lung water.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 26, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

February 11, 2025

Status Verified

February 1, 2025

Enrollment Period

3.6 years

First QC Date

July 19, 2022

Last Update Submit

February 9, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Association between the transpulmonary driving pressure and the extravascular lung water (EVLW)

    On the first day of patient's respiratory and hemodynamics monitoring, we will collect transpulmonary driving pressure and extra-vascular lung water values. We will calculate the correlation coefficient linking these two variables to assess if their association.

    From inclusion up to hospital discharge (maximum day 60)

Secondary Outcomes (7)

  • Association between the transpulmonary driving pressure and the pulmonary vascular permeability index (PVPI)

    From inclusion up to hospital discharge (maximum day 60)

  • Correlation between the transpulmonary driving pressure at admission and the ICU-mortality

    From inclusion up to hospital discharge (maximum day 60)

  • Correlation between the extravascular lung water at admission and the ICU-mortality

    From inclusion up to hospital discharge (maximum day 60)

  • Influence of position on plateau pressure

    From inclusion up to hospital discharge (maximum day 60)

  • Influence of position on plateau pressure on esophageal pressure

    From inclusion up to hospital discharge (maximum day 60)

  • +2 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients intubated in the medical ICU of Bicêtre hospital (Academic hospital), Le Kremlin Bicêtre, France

You may qualify if:

  • Acute respiratory distress syndrome (ARDS)
  • Monitoring with a transpulmonary thermodilution device
  • Esophageal pressure monitoring

You may not qualify if:

  • Legal protection measures
  • Pregnancy
  • Contra-indications of esophageal catheter : esophageal varicose, severe coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Intensive Care Unit, Bicêtre Hospital

Le Kremlin-Bicêtre, France

RECRUITING

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Tài Pham, MD, PhD

    Hôpital Bicêtre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tài Pham, MD, PhD.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 19, 2022

First Posted

July 26, 2022

Study Start

February 1, 2022

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

February 11, 2025

Record last verified: 2025-02

Locations